Access the full text.
Sign up today, get DeepDyve free for 14 days.
Tandan Tandan, Bradley Bradley (1985)
Amyotrophic lateral sclerosis: part 1. Clinical features, pathology and ethical issues in managementAnn Neurol, 18
Perry Perry, Hansen Hansen, Jones Jones (1987)
Brain glutamate deficiency in amyotrophic lateral sclerosisNeurology, 37
Yoshino Yoshino, Koike Koike, Akaik Akaik (1979)
Free amino acids in motor neuron cortex of amyotrophic lateral sclerosisExperimentia, 35
Spencer Spencer, Nunn Nunn, Hugon Hugon (1987)
Guam amytrophic lateral sclerosis–parkinsonism–dementia linked to a plant excitant neurotoxinScience, 237
Schwarcz Schwarcz, Foster Foster, French French (1984)
Excitotoxic models for neurodegenerative disordersLife Sci, 35
Nakano Nakano, Hirano Hirano (1987)
Atrophic cell processes of large motor neurons in the anterior horn in amyotrophic lateral sclerosis: observations with silver impregnation methodJ Neuropathol Exp Neurol, 46
Perry Perry, Hansen Hansen, Grandham Grandham (1981)
Postmortem changes of amino compounds in human and rat brainJ Neurochem, 36
Robinson Robinson (1968)
Chemical changes in spinal cord in Friedreich's ataxia and motor neuron diseaseJ Neurol Neurosurg Psychiatry, 31
Plaitakis Plaitakis, Caroscio Caroscio (1987)
Abnormal glutamate metabolism in amytrophic lateral sclerosisAnn Neurol, 22
Plaitakis Plaitakis, Caroscio Caroscio (1985)
Abnormal glutamate metabolism in ALSAnn Neurol, 18
Hammer Hammer, Tomiyasu Tomiyasu, Scheibel Scheibel (1979)
Degeneration of human Betz cell due to amyotrophic lateral sclerosisExp Neurol, 63
Patten Patten, Kurlander Kurlander, Evans Evans (1982)
Free amino acid concentrations of spinal tissue from patients dying from motor neuron diseaseActa Neurol Scand, 66
Plaitakis Plaitakis, Berl Berl, Yahr Yahr (1982)
Abnormal glutamate metabolism in an adult onset degenerative neurological disorderScience, 216
Hornykiewicz Hornykiewicz (1973)
Parkinson's disease: from brain homogenate to treatmentFed Proc, 32
Because recent studies showed a systemic defect in glutamate metabolism in amyotrophic lateral sclerosis (ALS), we measured the levels of free amino acids in frontal and cerebellar cortex and two areas of spinal cord obtained at autopsy from 22 patients who died of this disease. Glutamate levels were significantly Decemberreased (by 21 to 40% of control values) in all areas investigated; cervical and lumbar spinal cord showed the greatest change. Aspartate levels were also significantly reduced (by 32 to 35%) in the spinal cord only. A positive correlation was shown between the changes of glutamate and aspartate as well as a significant alteration in the glutamate to glutamine ratio in the spinal cord of patients with ALS. Although we cannot exclude the possibility that these abnormalities may partly result from neuronal cell loss, the data suggest the presence of a generalized defect that may affect the neurotransmitter and metabolic pool of glutamate. The defect may be expressed more severely in the spinal cord than in other central nervous system areas. These results, taken together with the previously shown systemic abnormality, raise the possibility that distribution of glutamate between the intracellular and extracellular pool may be altered in ALS and may mediate the neurodegeneration.
Annals of Neurology – Wiley
Published: Sep 1, 1988
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.